Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott M Lippman

Showing results (91-100 of 340) with videos related to

Pageof 34
Sort By:
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 13, 2005
Increased retinoic acid receptor-beta4 correlates in vivo with reduced retinoic acid receptor-beta2 in esophageal squamous cell carcinomaXiao-chun Xu, J Jack Lee, Tsung-Teh Wu, et al.
Cancer|October 10, 2013
Short telomere lengths in peripheral blood leukocytes are associated with an increased risk of oral premalignant lesion and oral squamous cell carcinomaDa-Tian Bau, Scott M Lippman, Enping Xu, et al.
Molecular Cancer Therapeutics|October 8, 2011
Akt/mTOR counteract the antitumor activities of cixutumumab, an anti-insulin-like growth factor I receptor monoclonal antibodyDong Hoon Shin, Hye-Young Min, Adel K El-Naggar, et al.
Pancreas|October 17, 2018
Intercepting Pancreatic Cancer: Our Dream Team's Resolve to Stop Pancreatic CancerMichael G Goggins, Scott M Lippman, Pamela E Constantinou, et al.
Cancer|October 1, 2008
Genetic variations in cell-cycle pathway and the risk of oral premalignant lesionsYuanqing Ye, Scott M Lippman, J Jack Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2024
Deep Learning Artificial Intelligence Predicts Homologous Recombination Deficiency and Platinum Response From Histologic SlidesErik N Bergstrom, Ammal Abbasi, Marcos Díaz-Gay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2006
The role of prevention in oncology practice: results from a 2004 survey of American Society of Clinical Oncology members, Patricia A Ganz, Lorna Kwan, et al.
Blood|May 10, 2011
Antiangiogenic antitumor activities of IGFBP-3 are mediated by IGF-independent suppression of Erk1/2 activation and Egr-1-mediated transcriptional eventsJai-Hyun Kim, Dong Soon Choi, Ok-Hee Lee, et al.
International Journal of Oncology|March 11, 2004
Human telomerase reverse transcriptase mRNA is highly expressed in normal breast tissues and down-regulated in ductal carcinoma in situJinsong Liu, Atac Baykal, Kar-Ming Fung, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 10, 2004
Differential peroxisome proliferator-activated receptor-gamma isoform expression and agonist effects in normal and malignant prostate cellsVemparala Subbarayan, Anita L Sabichi, Jeri Kim, et al.
Pageof 34

Showing results (91-100 of 340) with videos related to

Sort By:
Pageof 34
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 13, 2005
Increased retinoic acid receptor-beta4 correlates in vivo with reduced retinoic acid receptor-beta2 in esophageal squamous cell carcinomaXiao-chun Xu, J Jack Lee, Tsung-Teh Wu, et al.
Cancer|October 10, 2013
Short telomere lengths in peripheral blood leukocytes are associated with an increased risk of oral premalignant lesion and oral squamous cell carcinomaDa-Tian Bau, Scott M Lippman, Enping Xu, et al.
Molecular Cancer Therapeutics|October 8, 2011
Akt/mTOR counteract the antitumor activities of cixutumumab, an anti-insulin-like growth factor I receptor monoclonal antibodyDong Hoon Shin, Hye-Young Min, Adel K El-Naggar, et al.
Pancreas|October 17, 2018
Intercepting Pancreatic Cancer: Our Dream Team's Resolve to Stop Pancreatic CancerMichael G Goggins, Scott M Lippman, Pamela E Constantinou, et al.
Cancer|October 1, 2008
Genetic variations in cell-cycle pathway and the risk of oral premalignant lesionsYuanqing Ye, Scott M Lippman, J Jack Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2024
Deep Learning Artificial Intelligence Predicts Homologous Recombination Deficiency and Platinum Response From Histologic SlidesErik N Bergstrom, Ammal Abbasi, Marcos Díaz-Gay, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 17, 2006
The role of prevention in oncology practice: results from a 2004 survey of American Society of Clinical Oncology members, Patricia A Ganz, Lorna Kwan, et al.
Blood|May 10, 2011
Antiangiogenic antitumor activities of IGFBP-3 are mediated by IGF-independent suppression of Erk1/2 activation and Egr-1-mediated transcriptional eventsJai-Hyun Kim, Dong Soon Choi, Ok-Hee Lee, et al.
International Journal of Oncology|March 11, 2004
Human telomerase reverse transcriptase mRNA is highly expressed in normal breast tissues and down-regulated in ductal carcinoma in situJinsong Liu, Atac Baykal, Kar-Ming Fung, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|November 10, 2004
Differential peroxisome proliferator-activated receptor-gamma isoform expression and agonist effects in normal and malignant prostate cellsVemparala Subbarayan, Anita L Sabichi, Jeri Kim, et al.
Pageof 34